Brookline Reaffirms Price Target for Moderna (MRNA) After Strong mRNA-1283 Vaccine Results

Moderna, Inc. (NASDAQ:MRNA) ranks among the best biotech stocks to buy. Following solid trial results for Moderna, Inc.

Moderna's COVID-19 Vaccine Update Boosts Antibodies 16-Fold, Data Shows

Moderna Inc. (NASDAQ:MRNA) on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of mNEXSPIKE ...

Pfizer, Moderna post data supporting COVID shots after Trump demand

Pfizer (PFE) and Moderna (MRNA) reveal trial data showing their updated COVID mRNA vaccines are safe and effective after President Donald Trump's demand. Read more here.
Seeking Alpha

Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent ...

Moderna says updated next-generation COVID shot shows strong immune response in patients

Moderna said on Tuesday its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and ...
The National Law Review

Moderna Announces Data to be Presented at ESMO Congress 2025

CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its investigational mRNA therapeutics have been accepted for presentation at the ...
Becker's Hospital Review

Moderna didn’t release enough data to prove vaccine is effective, experts say

Vaccine experts told STAT that the data Moderna released May 18 from its phase I vaccine trial isn’t enough to show whether or not the vaccine will be effective. Moderna released data from an early ...